In an increasingly competitive market, venture firms can improve their odds of survival by teaming up with larger PE firms with whom they have synergy. This week Sofinnova Partners, a Paris-based early-stage life sciences investor, sold a minority stake to Apollo in return for Apollo committing to invest up to €1 billion to its funds.